Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0W0ED
|
||||
Former ID |
DIB009984
|
||||
Drug Name |
Eflucimibe
|
||||
Synonyms |
F-12511
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Hyperlipidaemia [ICD9: 272.0-272.4; ICD10:E78] | Discontinued in Phase 2 | [546909] | ||
Company |
Pierre Fabre SA
|
||||
Structure |
Download2D MOL |
||||
Formula |
C29H43NO2S
|
||||
Canonical SMILES |
c1(NC(=O)[C@H](c2ccccc2)SCCCCCCCCCCCC)c(c(c(c(c1)C)O)C)<br />C
|
||||
CAS Number |
CAS 202340-45-2
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Liver carboxylesterase | Target Info | Inhibitor | [533663] | |
KEGG Pathway | Drug metabolism - other enzymes | ||||
Metabolic pathways | |||||
Pathway Interaction Database | E2F transcription factor network | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.